Frank Rabito, MD
Infectious Disease · Metairie, LANPI 1821080367
Payments from drug & device makers
Across 649 payments — averaging $19.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$2K
- Gilead$2K
- Paratek Pharmaceuticals, Inc.$1K
- AbbVie$1K
- Insmed, Inc.$1K
- Merck$960
- plus $5K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 130 | $2,288 |
| Gilead | 83 | $1,627 |
| Paratek Pharmaceuticals, Inc. | 67 | $1,241 |
| AbbVie(2 entities) | 65 | $1,033 |
| Insmed, Inc. | 56 | $1,014 |
| Merck | 57 | $960 |
| Theratechnologies Inc. | 24 | $599 |
| Johnson & Johnson(2 entities) | 28 | $489 |
| EMD Serono, Inc. | 18 | $388 |
| Melinta Therapeutics, LLC | 20 | $384 |
| Stryker | 2 | $341 |
| Organogenesis Inc. | 6 | $332 |
| Astellas Pharma US Inc | 16 | $319 |
| Napo Pharmaceuticals Inc | 13 | $236 |
| Shionogi Inc | 12 | $217 |
| Pfizer | 10 | $203 |
| Amarin Pharma, Inc. | 10 | $188 |
| Hydrofera LLC | 1 | $173 |
| Kerecis Limited | 2 | $159 |
| Mayne Pharma Commercial LLC | 6 | $152 |
| Mimedx Group, Inc. | 1 | $131 |
| Nabriva Therapeutics, PLC | 4 | $51 |
| La Jolla Pharmaceutical Company | 3 | $49 |
| Smith+Nephew | 2 | $49 |
| Pharming Healthcare, Inc. | 2 | $40 |
| Kowa Pharmaceuticals America, Inc. | 2 | $37 |
| Reprise Biomedical, Inc. | 1 | $29 |
| Vyera Pharmaceuticals, LLC | 1 | $25 |
| Accelerate Diagnostics Inc. | 1 | $20 |
| Amgen | 1 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $17 |
| Philips North America LLC | 1 | $15 |
| Tactile Systems Technology Inc | 1 | $15 |
| Cumberland Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$12,866 in reported general payments places this provider in the 75th percentile of 105 infectious disease providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Metairie
- John DepaulaMetairie$17K
- Anish ShahMetairie$4K
- Diane FaillaMetairie$2K
- Julia Garcia-DiazNew Orleans$9.9M
- Rebecca LillisNew Orleans$2.7M
- Jonathan HandNew Orleans$1.7M
- Stephanie TaylorNew Orleans$1.6M
- George PankeyNew Orleans$851K
- Meredith ClementNew Orleans$829K
- Joseph DalovisioNew Orleans$634K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.